HF004
In those patients with a current diagnosis of heart failure due to left ventricular systolic dysfunction who are currently treated with an ACE-I or ARB, the percentage of patients who are additionally currently treated with a beta- blocker licensed for heart failure for heart failure
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF004 | 2019 | 2423 | 2704 | 89.6% | |
| HF004 | 2020 | 2752 | 3107 | 88.6% | |
| HF006 | 2021 | 3812 | 4327 | 88.1% | |
| HF006 | 2022 | 4731 | 4978 | 95.0% | |
| HF006 | 2023 | 5922 | 6247 | 94.8% |
